Myasthenia Gravis

REGAIN Study

Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis Eculizumab (Especially for AchR- MG)

eculizumab was effective in improving symptoms of disease At week 26.

Eculizumab also significantly improved muscle strength

MGTX

Thymectomy improves symtoms over 3 year period in MG patients without thymoma